Benzinga - by Avi Kapoor, Benzinga Staff Writer.
Shares of Netflix, Inc. (NASDAQ: NFLX) shares rose sharply in today’s pre-market trading as the company reported better-than-expected sales for its fourth quarter.
Netflix reported fourth-quarter revenue of $8.83 billion, which was up 12.5% year-over-year. The total came in ahead of a Street consensus estimate of $8.72 billion. The company reported fourth-quarter earnings per share of $2.11, which missed a Street consensus estimate of $2.21.
The company, meanwhile, added 13.12 million net paid subscribers in the fourth quarter.
Netflix shares jumped 10.2% to $542.48 in pre-market trading
Here are some other stocks moving in pre-market trading.
Gainers
- Getaround, Inc. (NYSE: GETR) gained 50.7% to $0.2771 in pre-market trading after the company announced a new debt facility with Mudrick Capital Management for up to $20 million.
- Evaxion Biotech A/S (NASDAQ: EVAX) gained 43.2% to $7.15 in pre-market trading after a 13G filing showed Merck & Co reported an 11.4% stake in the company as of December 21, 2023.
- VS MEDIA Holdings Limited (NASDAQ: VSME) shares jumped 31.7% to $0.4318 in pre-market trading after gaining around 3% on Tuesday.
- Zoomcar Holdings, Inc. (NASDAQ: ZCAR) shares gained 18.1% to $3.98 in pre-market trading after gaining over 5% on Tuesday. Zoomcar recently appointed Adarsh Menon as President.
- RedHill Biopharma Ltd. (NASDAQ: RDHL) gained 17.8% to $1.05 in pre-market trading. Redhill Biopharma was granted U.S. Patent #11878011 for "Method for Eradicating Helicobacter Pylori Infection in Patients Regardless of Body Mass Index."
- Nyxoah S.A. (NASDAQ: NYXH) surged 17.7% to $6.59 in pre-market trading after surging over 20% on Tuesday.
- Greenidge Generation Holdings Inc. (NASDAQ: GREE) shares climbed 15.7% to $4.10 in pre-market trading after falling more than 10% on Tuesday.
- Cadrenal Therapeutics, Inc. (NASDAQ: CVKD) shares gained 10.7% to $1.14 in pre-market trading.
- Ensysce Biosciences, Inc. (NASDAQ: ENSC) shares gained 8.6% to $1.51 in pre-market trading. Ensysce Biosciences shares gained 22% on Tuesday after the company announced FDA Breakthrough Therapy Designation for PF614-MPAR.
- Meta Materials Inc. (NASDAQ: MMAT) shares dipped 16.2% to $0.0560 in pre-market trading. Meta Materials announced a 1-for-100 reverse stock split to regain Nasdaq compliance.
- BlackBerry Limited (NYSE: BB) shares fell 11% to $3.16 in pre-market trading after the company announced a proposed private offering of $160 million of convertible senior notes.
- vTv Therapeutics Inc. (NASDAQ: VTVT) shares fell 9.4% to $8.48 in pre-market trading.
- ETAO International Co., Ltd. (NASDAQ: ETAO) fell 8.9% to $0.2010 after dipping over 20% on Tuesday.
- Diversified Energy Company PLC (NYSE: DEC) fell 8.9% to $11.74 in pre-market trading.
- Sonoma Pharmaceuticals, Inc. (NASDAQ: SNOA) declined 8% to $0.1574 in pre-market trading. Sonoma pharmaceuticals announced the launch of Lumacyn Clarifying Mist direct to consumers for over-the-counter use in the US.
- Opthea Limited (NASDAQ: OPT) shares fell 7.9% to $2.44 in pre-market trading.
- HWH International Inc. (NASDAQ: HWH) shares declined 7.3% to $1.78 in pre-market trading after gaining more than 23% on Tuesday.
- FaZe Holdings Inc. (NASDAQ: FAZE) shares declined 6.9% to $0.2978 in pre-market trading. FaZe Holdings shares jumped 107% on Tuesday after the company announced Rollbit will sponsor its Counter-Strike team.
- Texas Instruments Incorporated (NASDAQ: TXN) shares dipped 3.7% to $167.88 in pre-market trading after the company reported fourth-quarter financial results.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.